Brief: Cue Health Explores Strategic Alternatives

Cue Health

09/04/2024 14:10

April 9 (Reuters) - Cue Health Inc  HLTH.O :
    * CUE HEALTH INC - HAS BEEN UNDERTAKING A COMPREHENSIVE
REVIEW OF
STRATEGIC ALTERNATIVES FOR COMPANY
    * CUE HEALTH INC - STRATEGIC REVIEW PROCESS IS INTENDED TO
EVALUATE A BROAD RANGE OF OPTIONS, INCLUDING A POTENTIAL SALE OF
COMPANY
    * CUE HEALTH-  STRATEGIC COMMITTEE DECIDED TO TAKE CERTAIN
ACTIONS
NEEDED TO PERMIT POTENTIAL COUNTERPARTIES TO ENGAGE IN
DISCUSSIONS WITH ONE ANOTHER
    * CUE HEALTH INC - STRATEGIC REVIEW PROCESS IS INTENDED TO
EVALUATE A BROAD RANGE OF OPTIONS, INCLUDING A POTENTIAL SALE OF
COMPANY
    * CUE HEALTH - FDA SAYS CUE RSV MOLECULAR TEST DOES NOT MEET
CRITERIA FOR CLASSIFICATION INTO CLASS I OR CLASS II FOR
PROPOSED OTC INDICATIONS OF USE

Source text for Eikon:  ID:n0001628945-24-000060 
Further company coverage:  HLTH.O 

 ((Reuters.Briefs@thomsonreuters.com;))